Westside Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.18M | Sell |
16,600
-50
| -0.3% | -$10.8K | 0.55% | 43 |
|
|
2026
Q1 | $3.6M | Sell |
16,650
-72
| -0.4% | -$16K | 0.55% | 44 |
|
|
2025
Q4 | $3.82M | Sell |
16,722
-250
| -1% | -$57K | 0.61% | 40 |
|
|
2025
Q3 | $3.96M | Sell |
16,972
-284
| -2% | -$57.8K | 0.63% | 38 |
|
|
2025
Q2 | $3.21M | Buy |
17,256
+87
| +0.5% | +$16.2K | 0.6% | 43 |
|
|
2025
Q1 | $3.59M | Sell |
17,169
-148
| -0.9% | -$28.8K | 0.77% | 34 |
|
|
2024
Q4 | $3.08M | Buy |
17,317
+21
| +0.1% | +$3.86K | 0.65% | 37 |
|
|
2024
Q3 | $3.4M | Buy |
17,296
+171
| +1% | +$31.9K | 0.72% | 35 |
|
|
2024
Q2 | $2.94M | Sell |
17,125
-274
| -2% | -$45.4K | 0.67% | 39 |
|
|
2024
Q1 | $3.17M | Sell |
17,399
-490
| -3% | -$84.4K | 0.76% | 33 |
|
|
2023
Q4 | $2.77M | Sell |
17,889
-140
| -0.8% | -$20.4K | 0.71% | 34 |
|
|
2023
Q3 | $2.69M | Hold |
18,029
| – | – | 0.77% | 31 |
|
|
2023
Q2 | $2.43M | Sell |
18,029
-100
| -0.6% | -$14.7K | 0.69% | 34 |
|
|
2023
Q1 | $2.89M | Sell |
18,129
-310
| -2% | -$47.4K | 0.85% | 28 |
|
|
2022
Q4 | $283K | Sell |
18,439
-80
| -0.4% | -$12.3K | 0.7% | 36 |
|
|
2022
Q3 | $234K | Sell |
18,519
-130
| -0.7% | -$18.7K | 0.56% | 48 |
|
|
2022
Q2 | $283K | Sell |
18,649
-70
| -0.4% | -$10.7K | 0.64% | 36 |
|
|
2022
Q1 | $283K | Sell |
18,719
-3,370
| -15% | -$490K | 0.62% | 38 |
|
|
2021
Q4 | $474K | Sell |
22,089
-270
| -1% | -$31.9K | 1.08% | 23 |
|
|
2021
Q3 | $474K | Buy |
22,359
+1,394
| +7% | +$159K | 1.09% | 23 |
|
|
2021
Q2 | $467K | Sell |
20,965
-100
| -0.5% | -$11.3K | 1.08% | 22 |
|
|
2021
Q1 | $383K | Buy |
21,065
+2,295
| +12% | +$245K | 1.01% | 24 |
|
|
2020
Q4 | $366K | Sell |
18,770
-63
| -0.3% | -$6.05K | 1% | 20 |
|
|
2020
Q3 | $323K | Buy |
18,833
+4,751
| +34% | +$447K | 0.15% | 19 |
|
|
2020
Q2 | $195K | Sell |
14,082
-1,666
| -11% | -$147K | 0.11% | 30 |
|
|
2020
Q1 | $11.4K | Buy |
+15,748
| New | +$1.34M | 0.01% | 141 |
|
|
2019
Q2 | $305 | Buy |
+4,206
| New | +$331K | ﹤0.01% | 168 |
|
|
2018
Q4 | $395K | Sell |
4,283
-136
| -3% | -$12K | 0.14% | 105 |
|
|
2018
Q3 | $420K | Hold |
4,419
| – | – | 0.13% | 98 |
|
|
2018
Q2 | $411K | Buy |
4,419
+51
| +1% | +$4.98K | 0.14% | 100 |
|
|
2018
Q1 | $399K | Sell |
4,368
-639
| -13% | -$70.2K | 0.22% | 102 |
|
|
2017
Q4 | $498K | Sell |
5,007
-1,145
| -19% | -$108K | 0.27% | 79 |
|
|
2017
Q3 | $558K | Buy |
6,152
+270
| +5% | +$20.6K | 0.34% | 72 |
|
|
2017
Q2 | $423K | Buy |
5,882
+400
| +7% | +$26.9K | 0.28% | 87 |
|
|
2017
Q1 | $356K | Buy |
5,482
+2,850
| +108% | +$179K | 0.17% | 89 |
|
|
2016
Q4 | $161K | Buy |
+2,632
| New | +$161K | 0.11% | 105 |
|
Other funds holding ABBV
Westside Investment Management's ABBV Position: Q2 2026 in Review
Westside Investment Management reduced its AbbVie (ABBV) stake by 0.3% in Q2 2026, selling an estimated $10.8K and leaving 16,600 shares worth $4.18M. The position accounts for 0.55% of the portfolio, ranked #43.
Westside Investment Management first reported a position in ABBV in Q4 2016 and has held it in 36 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Westside Investment Management held 16,600 shares of AbbVie worth $4.18M as of Q2 2026.
- Westside Investment Management sold 50 AbbVie shares in Q2 2026, an estimated $10.8K.
- AbbVie made up 0.55% of Westside Investment Management's portfolio in Q2 2026, its #43 holding.
- Westside Investment Management first reported a position in AbbVie in Q4 2016 and has held it in 36 quarters since.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.